col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


246 Results       Page 1

 [1] 
Springer-Verlag: Journal of Neurology
  original article Date Title Authors   All Authors
1 [GO] 2024―Jun―27 A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic Anoushka P. Lal, Yi Chao Foong, Paul G. Sanfilippo, Tim Spelman, Louise Rath, David Levitz, et al. (+49)
2 [GO] 2024―May―04 Cerebellar encephalitis and peripheral neuropathy with an atypical clinical and neuroimaging signature following Covid-19 vaccine: a report of two cases Marin Sicard, Natalia Shor, Vincent Davy, Jean-Jacques Rouby, Bruno Oquendo, Thierry Maisonobe, et al. (+10)
3 [GO] 2024―Apr―24 Neuropsychiatric complications of coronavirus disease 2019: Mount Sinai Health System cohort study Kapil Gururangan, Veronica J. Peschansky, Grace Van Hyfte, Parul Agarwal, Leah J. Blank, Brian Mathew, et al. (+27)
4 [GO] 2024―Mar―04 Outcome predictors of post-COVID conditions in the European Academy of Neurology COVID-19 registry Maurizio Angelo Leone, Raimund Helbok, Elisa Bianchi, Clarissa Lin Yasuda, Maria Konti, Dauren Ramankulov, et al. (+56)
5 [GO] 2024―Jan―17 Guillain-Barré syndrome and COVID-19 vaccination: a systematic review and meta-analysis Stefano Censi, Giandomenico Bisaccia, Sabina Gallina, Valentina Tomassini, Antonino Uncini
6 [GO] 2023―Dec―09 Subacute transverse myelitis of possible vasculitic origin after SARS-CoV2 and Varicella-Zoster virus infections: a case report Francesco Favruzzo, Anna Palmieri, Federico Giopato, Davide Cardellini, Alessandra Vidali, Domenico Marco Bonifati
7 [GO] 2023―Dec―06 Long-term neurological symptoms after acute COVID-19 illness requiring hospitalization in adult patients: insights from the ISARIC-COVID-19 follow-up study Denise Battaglini, Nicole M. White, Lavienraj Premraj, Barbara Wanjiru Citarella, Laura Merson, Chiara Robba, et al. (+595)
8 [GO] 2023―Nov―28 Systematic review and evidence gap mapping of biomarkers associated with neurological manifestations in patients with COVID-19 K. Z. A. Domingues, A. F. Cobre, R. E. L. Lazo, L. S. Amaral, L. M. Ferreira, F. S. Tonin, R. Pontarolo
9 [GO] 2023―Nov―20 The impact of COVID-19 infection, the pandemic and its associated control measures on patients with Pompe disease Maudy T. M. Theunissen, Renee M. van den Elsen, Tiffany L. House, Brad Crittenden, Pieter A. van Doorn, Ans T. van der Ploeg, et al. (+2)
10 [GO] 2023―Nov―20 COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients Alvino Bisecco, Federica Matrone, Marco Capobianco, Giovanna De Luca, Massimo Filippi, Franco Granella, et al. (+55)
11 [GO] 2023―Nov―09 Susac syndrome in a patient with migraine shortly after COVID-19 booster vaccination: more than a temporal relation? Stergios Tsitos, Adrian Danek, Andreas Straube
12 [GO] 2023―Nov―03 SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose Massimiliano Di Filippo, Diana Ferraro, Paolo Ragonese, Luca Prosperini, Giorgia Teresa Maniscalco, Antonio Gallo, et al. (+22)
13 [GO] 2023―Sep―22 Seasonal variation and temporal relationship to the COVID-19 pandemic of NMDA receptor antibody results Jonathan P. Rogers, Michael K. L. Chou, Thomas A. Pollak, Michael Eyre, Maria Krutikov, Andrew Church, et al. (+8)
14 [GO] 2023―Sep―11 Acute necrotizing encephalopathy associated with COVID-19: case series and systematic review Chang Geng, Weili Zhao, Zhijun Wang, Jin Wu, Dongxiao Jiang, Nan Jiang, et al. (+3)
15 [GO] 2023―Sep―08 Pitfalls and biases in neuroepidemiological studies of COVID-19 and the nervous system: a critical appraisal of the current evidence and future directions Ettore Beghi, Andrei Ivashynka, Giancarlo Logroscino, Fabricio Ferreira de Oliveira, Jori E. Fleisher, Oana M. Dumitrascu, et al. (+3)
16 [GO] 2023―Aug―17 Risk of breakthrough COVID-19 after vaccination among people with multiple sclerosis on disease-modifying therapies Ronen Spierer, Idit Lavi, Sivan Bloch, Marianna Mazar, Daniel Golan
17 [GO] 2023―Aug―15 Cerebrospinal fluid cytokines in COVID-19: a review and meta-analysis Lily Devlin, Grace Y. Gombolay
18 [GO] 2023―Aug―13 Central nervous system complications in SARS-CoV-2-infected patients Zhonggui Li, Danyu Lin, Xiaoshuang Xu, Xiaohuan Liu, Jieli Zhang, Kaixun Huang, et al. (+4)
19 [GO] 2023―Aug―03 Brain MRI findings in neurologically symptomatic COVID-19 patients: a systematic review and meta-analysis Amir Masoud Afsahi, Alexander M. Norbash, Shahla F. Syed, Maya Sedaghat, Ghazaleh Afsahi, Ramin Shahidi, et al. (+14)
20 [GO] 2023―Jul―30 Delirium in hospitalized COVID-19 patients: a prospective, multicenter, cohort study Wei Zhu, Yangjing Bai, Simin Li, Meng Zhang, Jian Chen, Peishan Xie, et al. (+3)
21 [GO] 2023―Jul―29 Neurological symptoms after COVID-19 vaccination: a report on the clinical presentation of the first 50 patients Ameli Gerhard, Vanessa Raeder, Helena Franziska Pernice, Fabian Boesl, Maria Schroeder, Jonathan Richter, et al. (+5)
22 [GO] 2023―Jul―29 Pediatric de novo movement disorders and ataxia in the context of SARS-CoV-2 Nina-Maria Wilpert, Ana Luísa de Almeida Marcelino, Ellen Knierim, Pasquale Incoronato, Elisa Sanchez-Sendin, Olga Staudacher, et al. (+8)
23 [GO] 2023―Jul―28 Assessment of COVID-19 lockdown effect on early Alzheimer Disease progression Carmen Peña-Bautista, Lourdes Álvarez-Sánchez, Inés Ferrer-Cairols, Lorena García-Vallés, Miguel Baquero, Consuelo Cháfer-Pericás
24 [GO] 2023―Jul―26 Longitudinal analysis and treatment of neuropsychiatric symptoms in post-acute sequelae of COVID-19 Emilie N. Liu, Jennifer H. Yang, Lucas Patel, Jasmine Arora, Amanda Gooding, Ronald Ellis, Jennifer S. Graves
25 [GO] 2023―May―23 The association between the number of symptoms and the severity of Post-COVID-Fatigue after SARS-CoV-2 infection treated in an outpatient setting Lena Schmidbauer, Inge Kirchberger, Yvonne Goßlau, Tobias D. Warm, Alexander Hyhlik-Dürr, Jakob Linseisen, Christa Meisinger
26 [GO] 2023―May―15 Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis Ahmed Abdelhak, Lorenzo Barba, Michele Romoli, Pascal Benkert, Francesco Conversi, Lucio D’Anna, et al. (+32)
27 [GO] 2023―Apr―28 Eating reflex epilepsy of presumed autoimmune etiology after SARS-CoV-2 vaccination Alberto Vogrig, Salvatore Versace, Gian Luigi Gigli, Martina Fabris, Jérôme Honnorat, Mariarosaria Valente
28 [GO] 2023―Apr―07 COVID-19 infection after SARS-CoV-2 mRNA vaccination in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD patients during the Omicron subvariant BA.1/2 wave in Singapore Tianrong Yeo, Rachel Wan En Siew, Muhammad Yaaseen Gulam, Janis Siew Noi Tye, Amelia Yun Yi Aw, Thanushiree Sivalingam, et al. (+5)
29 [GO] 2023―Apr―04 Posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome in patients with COVID-19 infection: is there a link? A systematic review and case report analysis Adriano Bonura, Gianmarco Iaccarino, Sergio Soeren Rossi, Fioravante Capone, Francesco Motolese, Rosalinda Calandrelli, et al. (+2)
30 [GO] 2023―Apr―03 Translocator protein (TSPO)-PET as diagnostic and monitoring tool in COVID-19 related MRI-negative brainstem encephalitis: a case report Johannes Wischmann, Laura M. Bartos, Matthias Brendel, Nathalie L. Albert, Robert Forbrig, Andreas Straube, Ilias Masouris
31 [GO] 2023―Mar―20 COVID-19 severity is related to poor executive function in people with post-COVID conditions Mar Ariza, Neus Cano, Bàrbara Segura, Ana Adan, Núria Bargalló, Xavier Caldú, et al. (+41)
32 [GO] 2023―Mar―18 A prospective study of cellular immune response to booster COVID-19 vaccination in multiple sclerosis patients treated with a broad spectrum of disease-modifying therapies Pascual Torres, Agustín Sancho-Saldaña, Anna Gil Sánchez, Silvia Peralta, Maria José Solana, Sofian Bakkioui, et al. (+5)
33 [GO] 2023―Mar―04 Psychological impact of COVID-19 containment on CADASIL patients S. Reyes, A. Jabouley, N. Alili, M. H. De Sanctis, C. Machado, A. Taleb, et al. (+3)
34 [GO] 2023―Feb―23 Patterns of acute ischemic stroke and intracranial hemorrhage in patients with COVID-19 Ulf Jensen-Kondering, Christoph J. Maurer, Hanna C. B. Brudermann, Marielle Ernst, Sam Sedaghat, Nils G. Margraf, et al. (+28)
35 [GO] 2023―Feb―16 Modifiable risk factors of COVID-19 in patients with multiple sclerosis: a single-centre case-control study Federico Montini, Agostino Nozzolillo, Paola M. V. Rancoita, Chiara Zanetta, Lucia Moiola, Federica Cugnata, et al. (+4)
36 [GO] 2023―Jan―24 Brain positron emission tomography (PET) and cognitive abnormalities one year after COVID-19 Roberta Ferrucci, Luca Cuffaro, Antonella Capozza, Chiara Rosci, Natale Maiorana, Elisabetta Groppo, et al. (+6)
37 [GO] 2023―Jan―19 MRI evidence of olfactory system alterations in patients with COVID-19 and neurological symptoms Serena Capelli, Anna Caroli, Antonino Barletta, Alberto Arrigoni, Angela Napolitano, Giulio Pezzetti, et al. (+6)
38 [GO] 2022―Dec―28 A rare case of a wall-eyed bilateral internuclear ophthalmoplegia (WEBINO) syndrome in a patient with cutaneous lupus erythematosus after COVID-19 infection Massimo Barbagallo, Dominik Straumann, Enrico Binaghi, Anton Schmick
39 [GO] 2022―Dec―22 The impact of the SARS-CoV-2-pandemic on patients with chronic inflammatory neuropathies: results from the German INHIBIT register Alina Hieke, Marie Spenner, Fynn Schmitz, Aurelian Schumacher, Maximilian Schröder, Rafael Klimas, et al. (+7)
40 [GO] 2022―Nov―18 Persistent hiccups as main COVID-19 manifestation with transient cytotoxic lesion of the corpus callosum splenium during the Omicron wave in the post-vaccination era Celeste Sassi, Emel Mehmed, Amir Alkhatib, Mario Alberto Forero-Padilla, Dragan S. Goranov, Sylvia Habermann, et al. (+3)
41 [GO] 2022―Nov―10 Vasculitic flare in a patient with anti-myelin-associated glycoprotein (MAG) antibody following mRNA-1273 SARS-CoV-2 vaccine Chiara Briani, Sergio Ferrari, Matteo Tagliapietra, Livio Trentin, Andrea Visentin
42 [GO] 2022―Nov―09 New-onset Myasthenia Gravis after SARS-CoV-2 infection: case report and literature review Yan Tereshko, Gian Luigi Gigli, Sara Pez, Alessandro De Pellegrin, Mariarosaria Valente
43 [GO] 2022―Oct―13 Natalizumab wearing-off symptoms: effect of extend interval dosing during Sars-CoV-2 pandemic Giuseppe Magro, Stefania Barone, Federico Tosto, Antonio De Martino, Domenico Santange lo, Lucia Manzo, et al. (+5)
44 [GO] 2022―Oct―12 New onset of Susac syndrome after mRNA COVID-19 vaccine: a case report Assunta Bianco, Francesca Colò, Silvia Falso, Rosellina Russo, Matteo Maria Carlà, Angelo Minucci, et al. (+5)
45 [GO] 2022―Oct―11 SARS-CoV-2 in patients with Friedreich ataxia Megan M. Shen, Layne N. Rodden, Kellie McIntyre, Adriana Arias, Victoria Profeta, Kimberly Schadt, David R. Lynch
46 [GO] 2022―Sep―30 Structural brain changes in patients with persistent headache after COVID-19 resolution Álvaro Planchuelo-Gómez, David García-Azorín, Ángel L. Guerrero, Margarita Rodríguez, Santiago Aja-Fernández, Rodrigo de Luis-García
47 [GO] 2022―Sep―27 Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis Frauke Stascheit, Ulrike Grittner, Sarah Hoffmann, Philipp Mergenthaler, Michael Schroeter, Tobias Ruck, et al. (+16)
48 [GO] 2022―Sep―16 Association of admission serum levels of neurofilament light chain and in-hospital mortality in geriatric patients with COVID-19 Francesca Marchegiani, Rina Recchioni, Fiorella Marcheselli, Mirko Di Rosa, Jacopo Sabbatinelli, Giulia Matacchione, et al. (+14)
49 [GO] 2022―Aug―08 The late onset of emotional distress in people with progressive multiple sclerosis during the Covid-19 pandemic: longitudinal findings from the CogEx study Anthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, Jeremy Chataway, Nancy D. Chiaravalloti, Gary Cutter, et al. (+12)
50 [GO] 2022―Jul―30 BNT162b2 mRNA COVID-19 vaccine three-dose safety and risk of COVID-19 in patients with myasthenia gravis during the alpha, delta, and omicron waves Alon Doron, Yoav Piura, Ifat Vigiser, Hadar Kolb, Keren Regev, Nahum Nesher, Arnon Karni
51 [GO] 2022―Jul―26 Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod Rocco Capuano, Manuela Altieri, Miriana Conte, Alvino Bisecco, Alessandro d’Ambrosio, Giovanna Donnarumma, et al. (+6)
52 [GO] 2022―Jul―08 Status epilepticus during the COVID-19 pandemic in Cologne, Germany: data from a retrospective, multicentre registry Felix Kohle, Marie Madlener, Emanuel Francesco Bruno, Gereon Rudolf Fink, Volker Limmroth, Lothar Burghaus, Michael Peter Malter
53 [GO] 2022―Jul―05 SARS-CoV-2 infection in multiple sclerosis patients: interaction with treatments, adjuvant therapies, and vaccines against COVID-19 Ana Muñoz-Jurado, Begoña M. Escribano, Eduardo Agüera, Javier Caballero-Villarraso, Alberto Galván, Isaac Túnez
54 [GO] 2022―Jul―04 Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestations Federico Verde, Ilaria Milone, Ilaria Bulgarelli, Silvia Peverelli, Claudia Colombrita, Alessio Maranzano, et al. (+7)
55 [GO] 2022―Jun―25 Anti-LGI1 encephalitis following COVID-19 vaccination: a case series Gian Maria Asioli, Lorenzo Muccioli, Valentina Barone, Sebastiano Giacomozzi, Simone Rossi, Tania Silvestri, et al. (+12)
56 [GO] 2022―Jun―23 MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature S. Jarius, N. Bieber, J. Haas, B. Wildemann
57 [GO] 2022―Jun―22 NMOSD typical brain lesions after COVID-19 mRNA vaccination Julie Lévi-Strauss, Corentin Provost, Noémie Wane, Thomas Jacquemont, Nicolas Mélé
58 [GO] 2022―May―18 Combined central and peripheral demyelination after COVID-19 vaccination Pedro Coelho, André Paula, Isabel Vidal Martins, Catarina Falcão de Campos, João Ferreira, Ana Patrícia Antunes, Luísa Albuquerque
59 [GO] 2022―May―10 Exploring trajectory recovery curves of post-COVID cognitive symptoms in previously hospitalized COVID-19 survivors: the LONG-COVID-EXP-CM multicenter study César Fernández-de-las-Peñas, José D. Martín-Guerrero, Ignacio Cancela-Cilleruelo, Jorge Rodríguez-Jiménez, Paloma Moro-López-Menchero, Oscar J. Pellicer-Valero
60 [GO] 2022―May―10 Intravenous immunoglobulins for treatment of severe COVID-19-related acute encephalopathy Shufan Huo, Caroline Ferse, Fabian Bösl, S. Momsen Reincke, Philipp Enghard, Carl Hinrichs, et al. (+9)
61 [GO] 2022―May―03 Vaccines and myasthenia gravis: a comprehensive review and retrospective study of SARS-CoV-2 vaccination in a large cohort of myasthenic patients Giulio Sansone, Domenico Marco Bonifati
62 [GO] 2022―May―03 Difference in safety and humoral response to mRNA SARS-CoV-2 vaccines in patients with autoimmune neurological disorders: the ANCOVAX study Maria Pia Giannoccaro, Veria Vacchiano, Marta Leone, Federico Camilli, Corrado Zenesini, Ivan Panzera, et al. (+22)
63 [GO] 2022―Apr―23 Anti-MOG associated disease with intracranial hypertension after COVID-19 vaccination Lina Jeantin, Adèle Hesters, Dorine Fournier, Bénédicte Lebrun-Vignes, Aurélie Méneret, Caroline Papeix, et al. (+2)
64 [GO] 2022―Apr―08 Cerebral venous sinus thrombosis in the setting of COVID-19 vaccination: a systematic review and meta-analysis Lina Palaiodimou, Maria-Ioanna Stefanou, Diana Aguiar de Sousa, Jonathan M. Coutinho, Marianna Papadopoulou, Vasiliki Papaevangelou, et al. (+4)
65 [GO] 2022―Mar―30 Neuroimmune disorders in COVID-19 Helena Ariño, Rosie Heartshorne, Benedict D. Michael, Timothy R. Nicholson, Angela Vincent, Thomas A. Pollak, Alberto Vogrig
66 [GO] 2022―Mar―25 Long-term cognitive impairments following COVID-19: a possible impact of hypoxia Thibaut Dondaine, Florine Ruthmann, Fanny Vuotto, Louise Carton, Patrick Gelé, Karine Faure, et al. (+2)
67 [GO] 2022―Mar―22 Decline in the number of patients with meningitis in German hospitals during the COVID-19 pandemic Stefanie Völk, Markus Pfirrmann, Uwe Koedel, Hans-Walter Pfister, Thomas Lang, Franziska Scheibe, et al. (+27)
68 [GO] 2022―Mar―14 Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies M. Allman, E. Tallantyre, N. P. Robertson
69 [GO] 2022―Mar―06 Cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study Giordano Cecchetti, Federica Agosta, Elisa Canu, Silvia Basaia, Alessandra Barbieri, Rosalinda Cardamone, et al. (+15)
70 [GO] 2022―Mar―02 Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod Anat Achiron, Mathilda Mandel, Michael Gurevich, Sapir Dreyer-Alster, David Magalashvili, Polina Sonis, et al. (+5)
71 [GO] 2022―Feb―22 Correction to: Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centre Alvaro Cobo-Calvo, Ana Zabalza, Jordi Río, Georgina Arrambide, Susana Otero-Romero, Paula Tagliani, et al. (+18)
72 [GO] 2022―Jan―22 Neuromyelitis optica spectrum disorder following COVID-19 infection with increase in pre-existing anti-aquaporin-4 antibodies Alexandre Jentzer, Clarisse Carra-Dallière, Claire Lozano, Sophie Riviere, Olivier Darmon, Xavier Ayrignac, et al. (+2)
73 [GO] 2022―Jan―10 Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centre Alvaro Cobo-Calvo, Ana Zabalza, Jordi Río, Georgina Arrambide, Susana Otero-Romero, Paula Tagliani, et al. (+18)
74 [GO] 2022―Jan―09 A comparative safety study of reported neurological adverse events with three COVID-19 vaccines Mohit Sodhi, Ali Samii, Mahyar Etminan
75 [GO] 2022―Jan―08 CGRP-monoclonal antibodies and SARS-CoV-2 vaccination Francesca Schiano di Cola, Salvatore Caratozzolo, Paolo Liberini, Alessandro Padovani, Renata Rao
76 [GO] 2022―Jan―04 Determinants of COVID-19-related lethality in multiple sclerosis: a meta-regression of observational studies Luca Prosperini, Carla Tortorella, Shalom Haggiag, Serena Ruggieri, Simonetta Galgani, Claudio Gasperini
77 [GO] 2022―Jan―03 Encephalopathy as a prognostic factor in adults with acute disseminated encephalomyelitis following COVID-19 Stefano Gelibter, Gabriele Bellavia, Carla Arbasino, Natale Arnò, Margaret Glorioso, Sara Mazza, et al. (+3)
78 [GO] 2021―Nov―05 The impact of the COVID-19 pandemic on an international rehabilitation study in MS: the CogEx experience Anthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, Jeremy Chataway, Nancy D. Chiaravalloti, Gary Cutter, et al. (+12)
79 [GO] 2021―Nov―01 Varicella zoster virus-induced neurological disease after COVID-19 vaccination: a retrospective monocentric study Samir Abu-Rumeileh, Benjamin Mayer, Veronika Still, Hayrettin Tumani, Markus Otto, Makbule Senel
80 [GO] 2021―Oct―21 Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions Ettore Beghi, Giorgia Giussani, Erica Westenberg, Ricardo Allegri, David Garcia-Azorin, Alla Guekht, et al. (+7)
81 [GO] 2021―Oct―15 The impact of the UK COVID-19 pandemic on patient-reported health outcomes after stroke: a retrospective sequential comparison Hatice Ozkan, Gareth Ambler, Gargi Banerjee, Edgar Chan, Simone Browning, John Mitchell, et al. (+7)
82 [GO] 2021―Oct―15 Ischemic stroke associated with COVID-19: a systematic review and meta-analysis Wenzhang Luo, Xiang Liu, Kunyang Bao, Changren Huang
83 [GO] 2021―Oct―07 COVID-19-related severe MS exacerbation with life-threatening Takotsubo cardiomyopathy in a previously stable patient and interference of MS therapy with long-term immunity against SARS-CoV-2 Brigitte Wildemann, Sven Jarius, Lorenz H. Lehmann, Florian André, Norbert Frey, Paul Schnitzler, et al. (+3)
84 [GO] 2021―Oct―05 SARS-CoV-2 antibody seroprevalence in a large neuroimmunological patient cohort Katharina Eisenhut, Stefan Buchka, Peter Eichhorn, Harald Meier, Fady Albashiti, Ulrich Mansmann, et al. (+3)
85 [GO] 2021―Oct―05 Case report: cerebral sinus vein thrombosis in two patients with AstraZeneca SARS-CoV-2 vaccination Mathias Fousse, David Schub, Fatma Merzou, Klaus Fassbender, Martina Sester, Michael Kettner, et al. (+3)
86 [GO] 2021―Sep―17 Increased risk of death from COVID-19 in multiple sclerosis: a pooled analysis of observational studies Luca Prosperini, Carla Tortorella, Shalom Haggiag, Serena Ruggieri, Simonetta Galgani, Claudio Gasperini
87 [GO] 2021―Sep―05 Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature Erum Khan, Ashish K. Shrestha, Mark A. Colantonio, Richard N. Liberio, Shitiz Sriwastava
88 [GO] 2021―Sep―04 COVID-19 manifestations in people with Parkinson’s disease: a USA cohort Yaqian Xu, Matthew Surface, Amanda K. Chan, Joshua Halpern, Nora Vanegas-Arroyave, Blair Ford, et al. (+11)
89 [GO] 2021―Sep―04 COVID-19 mRNA vaccination leading to CNS inflammation: a case series Mahsa Khayat-Khoei, Shamik Bhattacharyya, Joshua Katz, Daniel Harrison, Shahamat Tauhid, Penny Bruso, et al. (+3)
90 [GO] 2021―Aug―30 SARS-CoV-2-associated acute disseminated encephalomyelitis: a systematic review of the literature Yumin Wang, Yanchao Wang, Liang Huo, Qiang Li, Jichao Chen, Hongquan Wang
91 [GO] 2021―Aug―25 COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitis Simon Faissner, Daniel Richter, Ulas Ceylan, Christiane Schneider-Gold, Ralf Gold
92 [GO] 2021―Aug―21 Neurological consequences of recreational nitrous oxide abuse during SARS-CoV-2 pandemic Raphael Vollhardt, Julie Mazoyer, Lucy Bernardaud, Andrei Haddad, Pauline Jaubert, Irène Coman, et al. (+3)
93 [GO] 2021―Aug―12 Association of CNS demyelination and COVID-19 infection: an updated systematic review Ismail Ibrahim Ismail, Sara Salama
94 [GO] 2021―Aug―11 Decrease in intravenous thrombolysis and poor short-term functional prognosis for acute ischemic stroke during the COVID-19 pandemic Xueqian Xu, Yuenan Xiao, Jia Li, Liuzhu Chen, Gangqiang Lin, Ledan Dong, et al. (+4)
95 [GO] 2021―Jul―31 Delays in thrombolysis during COVID-19 are associated with worse neurological outcomes: the Society of Vascular and Interventional Neurology Multicenter Collaboration Dinesh V. Jillella, Fadi Nahab, Thanh N. Nguyen, Mohamad Abdalkader, David S. Liebeskind, Nirav Vora, et al. (+17)
96 [GO] 2021―Jul―27 Covid-19 and Parkinson’s disease: an overview S. M. Cartella, C. Terranova, V. Rizzo, A. Quartarone, P. Girlanda
97 [GO] 2021―Jul―24 Misinterpretation of glioblastoma as ADEM: potentially harmful consequences of over-diagnosis of COVID-19 vaccine-associated adverse events C. O´Sullivan, F. Zach, T. Moser, G. Pilz, A. Harrer, E. Trinka, et al. (+3)
98 [GO] 2021―Jul―21 Posterior Reversible Encephalopathy Syndrome and brain haemorrhage as COVID-19 complication: a review of the available literature Francesco Motolese, Mario Ferrante, Mariagrazia Rossi, Alessandro Magliozzi, Martina Sbarra, Francesca Ursini, et al. (+6)
99 [GO] 2021―Jul―03 COVID-19 and Parkinson’s disease: a casual association or a possible second hit in neurodegeneration? Francesco Cavallieri, Valentina Fioravanti, Giulia Toschi, Sara Grisanti, Manuela Napoli, Claudio Moratti, et al. (+9)
100 [GO] 2021―Jun―29 Serological response to SARS-CoV-2 vaccination in multiple sclerosis patients treated with fingolimod or ocrelizumab: an initial real-life experience Guerrieri S., Lazzarin S., Zanetta C., Nozzolillo A., Filippi M., Moiola L.
101 [GO] 2021―Jun―18 Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex Jacques Hugon, Eva-Flore Msika, Mathieu Queneau, Karim Farid, Claire Paquet
102 [GO] 2021―Jun―15 Acute bilateral optic/chiasm neuritis with longitudinal extensive transverse myelitis in longstanding stable multiple sclerosis following vector-based vaccination against the SARS-CoV-2 Christoph Helmchen, Gesine M. Buttler, Robert Markewitz, Katja Hummel, Heinz Wiendl, Tobias Boppel
103 [GO] 2021―Jun―11 First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine Joachim Havla, Yannick Schultz, Hanna Zimmermann, Reinhard Hohlfeld, Adrian Danek, Tania Kümpfel
104 [GO] 2021―Jun―11 Global survey on disruption and mitigation of neurological services during COVID-19: the perspective of global international neurological patients and scientific associations Chahnez Charfi Triki, Matilde Leonardi, Salma Zouari Mallouli, Martina Cacciatore, Kimberly Coard Karlshoej, Francesca Giulia Magnani, et al. (+9)
105 [GO] 2021―Jun―03 Altered mental status in COVID-19 Daniel Antoniello, Mark J. Milstein, Joseph Dardick, Jenelys Fernandez-Torres, Jenny Lu, Nikunj Patel, Charles Esenwa
106 [GO] 2021―Jun―03 Impact of the COVID-19 lockdown on the adherence of stroke patients to direct oral anticoagulants: a secondary analysis from the MAAESTRO study Fine Dietrich, Alexandros A. Polymeris, Melina Verbeek, Stefan T. Engelter, Kurt E. Hersberger, Sabine Schaedelin, et al. (+2)
107 [GO] 2021―May―25 Bell’s palsy following a single dose of mRNA SARS-CoV-2 vaccine: a case report C. Martin-Villares, A. Vazquez-Feito, M. J. Gonzalez-Gimeno, B. de la Nogal-Fernandez
108 [GO] 2021―May―24 SARS-CoV-2 infection and acute ischemic stroke in Lombardy, Italy Alessandro Pezzini, Mario Grassi, Giorgio Silvestrelli, Martina Locatelli, Nicola Rifino, Simone Beretta, et al. (+42)
109 [GO] 2021―May―22 Disruptions of neurological services, its causes and mitigation strategies during COVID-19: a global review David García-Azorín, Katrin M. Seeher, Charles R. Newton, Njideka U. Ok뫞jo, Andrea Pilotto, Deanna Saylor, et al. (+3)
110 [GO] 2021―May―22 Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis Tilmann Graf, Thomas Thiele, Randolf Klingebiel, Andreas Greinacher, Wolf-Rüdiger Schäbitz, Isabell Greeve
111 [GO] 2021―May―19 COVID-19 and neuroinflammation: a literature review of relevant neuroimaging and CSF markers in central nervous system inflammatory disorders from SARS-COV2 Shitiz Sriwastava, Medha Tandon, Sanjiti Podury, Apoorv Prasad, Sijin Wen, Garret Guthrie, et al. (+5)
112 [GO] 2021―May―18 Brainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung Gaetano Bulfamante, Tommaso Bocci, Monica Falleni, Laura Campiglio, Silvia Coppola, Delfina Tosi, et al. (+2)
113 [GO] 2021―May―17 Navigating migraine care through the COVID-19 pandemic: an update Heather Angus-Leppan, Angelica E. Guiloff, Karen Benson, Roberto J. Guiloff
114 [GO] 2021―May―10 Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients Rebecca De Lorenzo, Nicola I. Loré, Annamaria Finardi, Alessandra Mandelli, Daniela M. Cirillo, Cristina Tresoldi, et al. (+7)
115 [GO] 2021―May―05 The impact of Coronavirus disease 2019 (COVID-19) pandemic on migraine disorder Faraidoon Haghdoost, Cheryl Carcel, Deepak Chandrasekhar, Anthony Rodgers, Candice Delcourt
116 [GO] 2021―May―03 Neurological and cognitive sequelae of Covid-19: a four month follow-up Flavia Mattioli, Chiara Stampatori, Francesca Righetti, Emma Sala, Cesare Tomasi, Giuseppe De Palma
117 [GO] 2021―Apr―30 Neurological update: COVID-19 A. L. Ren, R. J. Digby, E. J. Needham
118 [GO] 2021―Apr―29 Intraluminal carotid thrombosis and acute ischemic stroke associated with COVID-19 Diaa Hamouda, Dinesh V. Jillella, Nirav Bhatt, Sitara Koneru, Michael R. Frankel, Raul G. Nogueira
119 [GO] 2021―Apr―28 Spontaneous spinal cord ischemia during COVID-19 infection Francesco Bax, Gian Luigi Gigli, Francesca Iaiza, Mariarosaria Valente
120 [GO] 2021―Apr―27 COVID-19 in a patient treated with eculizumab for aquaporin-4 neuromyelitis optica Ana Maria Cabal-Herrera, Farrah J. Mateen
121 [GO] 2021―Apr―25 Serum neurofilament light chain (sNfL) values in a large cross-sectional population of children with asymptomatic to moderate COVID-19 Tobias Geis, Susanne Brandstetter, Antoaneta A. Toncheva, Otto Laub, Georg Leipold, Ralf Wagner, et al. (+4)
122 [GO] 2021―Apr―21 SARS-CoV-2-related encephalitis with prominent parkinsonism: clinical and FDG-PET correlates in two patients Mauro Morassi, Francesco Palmerini, Stefania Nici, Eugenio Magni, Giordano Savelli, Ugo Paolo Guerra, et al. (+3)
123 [GO] 2021―Apr―19 Neurosensory dysphagia in a COVID-19 patient Alessia Zanon, Laura Cacciaguerra, Gabriele Martelli, Massimo Filippi
124 [GO] 2021―Apr―16 Comment on the paper Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab: the likely explanation for this phenomenon based on our observations Hubert Mado, Monika Adamczyk-Sowa
125 [GO] 2021―Apr―15 Atrioventricular block after fingolimod resumption: a consequence of sphingosine-1-phosphate axis alteration due to COVID-19? Mario Orrico, Agostino Nozzolillo, Stefano Gelibter, Francesca Sangalli, Paolo Preziosa, Massimo Filippi, Lucia Moiola
126 [GO] 2021―Apr―12 Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus Diego Centonze, Maria A. Rocca, Claudio Gasperini, Ludwig Kappos, Hans-Peter Hartung, Melinda Magyari, et al. (+4)
127 [GO] 2021―Apr―08 Palilalia as a prominent feature of anti-NMDA receptor encephalitis in a woman with COVID-19 Andrew W. McHattie, Jan Coebergh, Faraan Khan, Francesca Morgante
128 [GO] 2021―Apr―01 Management considerations for stroke-like episodes in MELAS with concurrent COVID-19 infection Kuntal Sen, Dana Harrar, Andrea Hahn, Elizabeth M. Wells, Andrea L. Gropman
129 [GO] 2021―Mar―20 Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19 Anne Hege Aamodt, Einar August Høgestøl, Trine Haug Popperud, Jan Cato Holter, Anne Ma Dyrhol-Riise, Kristian Tonby, et al. (+9)
130 [GO] 2021―Mar―18 Brainstem clinical and neurophysiological involvement in COVID-19 Tommaso Bocci, Gaetano Bulfamante, Laura Campiglio, Silvia Coppola, Monica Falleni, Davide Chiumello, Alberto Priori
131 [GO] 2021―Mar―17 Could symptom overlap of COVID-19 and Guillain-Barré syndrome mask an epidemiological association? Martin K. R. Svačina, Felix Kohle, Alina Sprenger, Helmar C. Lehmann
132 [GO] 2021―Mar―15 Neurology and vaccinations: considerations in the context of COVID-19/SARS-COV-2 M. Cauchi, N. P. Robertson
133 [GO] 2021―Mar―11 Intravenous immunoglobulin response in new-onset refractory status epilepticus (NORSE) COVID-19 adult patients Paolo Manganotti, Giovanni Furlanis, Miloš Ajčević, Cristina Moras, Lucia Bonzi, Valentina Pesavento, Alex Buoite Stella
134 [GO] 2021―Mar―08 Impact of SARS-CoV-2 on reperfusion therapies for acute ischemic stroke in Lombardy, Italy: the STROKOVID network Alessandro Pezzini, Mario Grassi, Giorgio Silvestrelli, Martina Locatelli, Nicola Rifino, Simone Beretta, et al. (+42)
135 [GO] 2021―Feb―27 Hospital admissions of acute cerebrovascular diseases during and after the first wave of the COVID-19 pandemic: a state-wide experience from Austria Thomas Gattringer, Simon Fandler-Höfler, Markus Kneihsl, Edith Hofer, Wolfgang Köle, Reinhold Schmidt, et al. (+3)
136 [GO] 2021―Feb―27 Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab Mahsa Khayat-Khoei, Sarah Conway, Douglas A. Rubinson, Petr Jarolim, Maria K. Houtchens
137 [GO] 2021―Feb―22 Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review Jason L. Chan, Keely A. Murphy, Justyna R. Sarna
138 [GO] 2021―Feb―22 Cerebral venous sinus thrombosis associated with COVID-19: a case series and literature review Vahid Reza Ostovan, Razieh Foroughi, Mahtab Rostami, Mostafa Almasi-Dooghaee, Manouchehr Esmaili, Ali Akbar Bidaki, et al. (+18)
139 [GO] 2021―Feb―21 Bell’s palsy following COVID-19 vaccination Giuseppe Colella, Massimiliano Orlandi, Nicola Cirillo
140 [GO] 2021―Feb―20 COVID-19 in multiple sclerosis patients treated with dimethyl fumarate Fioravante Capone, Elisabetta Ferraro, Francesco Motolese, Vincenzo Di Lazzaro
141 [GO] 2021―Feb―19 Serum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms V. A. Blanco-Palmero, F. J. Azcárate-Díaz, M. Ruiz-Ortiz, M. I. Laespada-García, P. Rábano-Suárez, A. Méndez-Guerrero, et al. (+7)
142 [GO] 2021―Feb―19 COVID-19-induced exacerbation of chronic inflammatory demyelinating polyneuropathy Eveline Van Looy, Len Veenker, Aurelia Steyaert, Jo Leenders, Goedele Malfroid, Harald De Cauwer
143 [GO] 2021―Feb―08 Characteristics of intracerebral haemorrhage associated with COVID-19: a systematic review and pooled analysis of individual patient and aggregate data R. Beyrouti, J. G. Best, A. Chandratheva, R. J. Perry, D. J. Werring
144 [GO] 2021―Feb―04 Complement inhibition initiated recovery of a severe myasthenic crisis with COVID-19 Ulrich Hofstadt-van Oy, Slobodan Stankovic, Corinna Kelbel, Daniel Oswald, Simon Larrosa-Lombardi, Thomas Barchfeld, Ulrich Cleff
145 [GO] 2021―Jan―23 Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) Biyan Nathanael Harapan, Hyeon Joo Yoo
146 [GO] 2021―Jan―13 Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up Vardan Nersesjan, Moshgan Amiri, Anne-Mette Lebech, Casper Roed, Helene Mens, Lene Russell, et al. (+15)
147 [GO] 2021―Jan―02 COVID-19 in children with neuromuscular disorders Daniel Natera-de Benito, Sergio Aguilera-Albesa, Laura Costa-Comellas, Mar García-Romero, María Concepción Miranda-Herrero, Júlia Rúbies Olives, et al. (+9)
148 [GO] 2021―Jan―02 SARS-CoV-2 infection in patients with primary central nervous system lymphoma Alice Laurenge, Renata Ursu, Caroline Houillier, Basma Abdi, Gianpiero Tebano, Cyril Quemeneur, et al. (+19)
149 [GO] 2020―Nov―26 Mononeuritis multiplex: an unexpectedly frequent feature of severe COVID-19 Edward Needham, Virginia Newcombe, Andrew Michell, Rachel Thornton, Andrew Grainger, Fahim Anwar, et al. (+4)
150 [GO] 2020―Nov―21 Critical illness-associated cerebral microbleeds for patients with severe COVID-19: etiologic hypotheses François Lersy, Thibault Willaume, Jean-Christophe Brisset, Olivier Collange, Julie Helms, Francis Schneider, et al. (+6)
151 [GO] 2020―Nov―20 COVID-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience Paolo Preziosa, Maria A. Rocca, Agostino Nozzolillo, Lucia Moiola, Massimo Filippi
152 [GO] 2020―Nov―20 Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up Julia V. Wanschitz, Manuela Kaml, Bettina Pfausler, Raimund Helbok, Sophie Wildner, Gerlig Widmann, et al. (+6)
153 [GO] 2020―Oct―30 Neurological manifestations of patients infected with the SARS-CoV-2: a systematic review of the literature Federico Cagnazzo, Caroline Arquizan, Imad Derraz, Cyril Dargazanli, Pierre-Henri Lefevre, Carlos Riquelme, et al. (+5)
154 [GO] 2020―Oct―26 Management of Parkinson's disease patients after DBS by remote programming: preliminary application of single center during quarantine of 2019-nCoV Jinyu Xu, Jiali Wang, Simfukwe Keith, Mingyang Zhang, Chunhui Yang, Qing Yuan, et al. (+3)
155 [GO] 2020―Oct―26 The neurological sequelae of pandemics and epidemics Fernanda Valerio, Daniel P. Whitehouse, David K. Menon, Virginia F. J. Newcombe
156 [GO] 2020―Oct―24 COVID-19 in Parkinson’s disease: what holds the key? R. Sainz-Amo, B. Baena-Álvarez, I. Pareés, G. Sánchez-Díez, P. Pérez-Torre, J. L. López-Sendón, et al. (+7)
157 [GO] 2020―Oct―20 Correction to: The immediate impact of the COVID-19 pandemic on motor neuron disease services and mortality in Scotland Stella A. Glasmacher, Juan Larraz, Arpan R. Mehta, Patrick K. A. Kearns, Michael Wong, Judith Newton, et al. (+6)
158 [GO] 2020―Oct―12 New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review Shitiz Sriwastava, Medha Tandon, Saurabh Kataria, Maha Daimee, Shumaila Sultan
159 [GO] 2020―Oct―08 Intravenous immunoglobulin therapy in COVID-19-related encephalopathy Lorenzo Muccioli, Umberto Pensato, Giorgia Bernabè, Lorenzo Ferri, Maria Tappatà, Lilia Volpi, et al. (+14)
160 [GO] 2020―Oct―07 Neurologic manifestations in 1760 COVID-19 patients admitted to Papa Giovanni XXIII Hospital, Bergamo, Italy Nicola Rifino, Bruno Censori, Emanuela Agazzi, Dario Alimonti, Virginio Bonito, Giorgia Camera, et al. (+18)
161 [GO] 2020―Sep―22 A word of hope for ataxia trials in COVID-19 time and beyond Roderick P. P. W. M. Maas, Jordache Ramjith, Thomas Klockgether, Kit C. B. Roes, Bart P. C. van de Warrenburg
162 [GO] 2020―Sep―20 Stroke care in Italy at the time of the COVID-19 pandemic: a lesson to learn Anna Bersano, Leonardo Pantoni
163 [GO] 2020―Sep―17 A rare case of acute motor axonal neuropathy and myelitis related to SARS-CoV-2 infection Fabio Giuseppe Masuccio, Massimo Barra, Geda Claudio, Solaro Claudio
164 [GO] 2020―Sep―12 COVID-19 infection in NMO/SD patients: a French survey Sinéad Zeidan, Elisabeth Maillart, Céline Louapre, Thomas Roux, Catherine Lubetzki, Caroline Papeix
165 [GO] 2020―Sep―10 Acute new-onset symptomatic seizures in the context of mild COVID-19 infection Maria Gaughan, Sean Connolly, Shamindra Direkze, Justin A. Kinsella
166 [GO] 2020―Sep―10 Effect of the COVID-19 pandemic on acute stroke reperfusion therapy: data from the Lyon Stroke Center Network Cécile Plumereau, Tae-Hee Cho, Marielle Buisson, Camille Amaz, Matteo Cappucci, Laurent Derex, et al. (+15)
167 [GO] 2020―Sep―10 Spinal epidural abscess in COVID-19 patients G. Talamonti, Davide Colistra, Francesco Crisà, Marco Cenzato, Pietro Giorgi, Giuseppe D’Aliberti
168 [GO] 2020―Sep―05 Correction to: Pre-existing cerebrovascular disease and poor outcomes of COVID-19 hospitalized patients: a meta-analysis Urvish Patel, Preeti Malik, Dhaivat Shah, Achint Patel, Mandip Dhamoon, Vishal Jani
169 [GO] 2020―Sep―05 The immediate impact of the COVID-19 pandemic on motor neuron disease services and mortality in Scotland Stella A. Glasmacher, Juan Larraz, Arpan R. Mehta, Patrick K. A. Kearns, Michael Wong, Judith Newton, et al. (+6)
170 [GO] 2020―Sep―03 Bickerstaff encephalitis after COVID-19 Lucía Llorente Ayuso, Pedro Torres Rubio, Rafael Fernando Beijinho do Rosário, María Luisa Giganto Arroyo, Fernando Sierra-Hidalgo
171 [GO] 2020―Sep―03 Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region Eleonora Del Prete, Alessio Francesconi, Giovanni Palermo, Sonia Mazzucchi, Daniela Frosini, Riccardo Morganti, et al. (+15)
172 [GO] 2020―Sep―03 Parainfectious encephalitis in COVID-19: “The Claustrum Sign” Frédéric Zuhorn, Hassan Omaimen, Bertram Ruprecht, Christoph Stellbrink, Michael Rauch, Andreas Rogalewski, et al. (+2)
173 [GO] 2020―Sep―01 Why do SARS-CoV-2 NSPs rush to the ER? Maryline Santerre, Sterling P. Arjona, Charles NS Allen, Natalia Shcherbik, Bassel E. Sawaya
174 [GO] 2020―Aug―31 Mild COVID-19 infection in a group of teriflunomide-treated patients with multiple sclerosis Vittorio Mantero, Damiano Baroncini, Roberto Balgera, Clara Guaschino, Paola Basilico, Pietro Annovazzi, et al. (+3)
175 [GO] 2020―Aug―27 COVID-19: dealing with a potential risk factor for chronic neurological disorders Tommaso Schirinzi, Doriana Landi, Claudio Liguori
176 [GO] 2020―Aug―25 Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases Samir Abu-Rumeileh, Ahmed Abdelhak, Matteo Foschi, Hayrettin Tumani, Markus Otto
177 [GO] 2020―Aug―19 The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis Nancy D. Chiaravalloti, Maria Pia Amato, Giampaolo Brichetto, Jeremy Chataway, Ulrik Dalgas, John DeLuca, et al. (+12)
178 [GO] 2020―Aug―19 How important are the team dynamics in the battle against COVID-19? Kajal Ruparell
179 [GO] 2020―Aug―18 Cytotoxic lesions of the corpus callosum (CLOCCs) associated with SARS-CoV-2 infection Anthony Moreau, Amedee Ego, Frederic Vandergheynst, Fabio Silvio Taccone, Niloufar Sadeghi, Isabel Montesinos, et al. (+2)
180 [GO] 2020―Aug―17 Management of patients with neuromuscular disorders at the time of the SARS-CoV-2 pandemic Gianluca Costamagna, Elena Abati, Nereo Bresolin, Giacomo Pietro Comi, Stefania Corti
181 [GO] 2020―Aug―14 Severe neurological complications in critically ill COVID-19 patients Quirin Notz, Christopher Lotz, Johannes Herrmann, Marius Vogt, Tobias Schlesinger, Markus Kredel, et al. (+5)
182 [GO] 2020―Aug―09 Acute necrotizing myelitis and acute motor axonal neuropathy in a COVID-19 patient Catalina Maideniuc, Anza B. Memon
183 [GO] 2020―Aug―08 Pre-existing cerebrovascular disease and poor outcomes of COVID-19 hospitalized patients: a meta-analysis Urvish Patel, Preeti Malik, Dhaivat Shah, Achint Patel, Mandip Dhamoon, Vishal Jani
184 [GO] 2020―Aug―08 SARS-CoV-2 associated Guillain-Barré syndrome Teodor Pelea, Ursula Reuter, Christine Schmidt, Raimondo Laubinger, Robert Siegmund, Bjoern Wito Walther
185 [GO] 2020―Aug―07 Neurological features in SARS-CoV-2-infected patients with smell and taste disorder Antoniangela Cocco, Paolo Amami, Antonio Desai, Antonio Voza, Fabio Ferreli, Alberto Albanese
186 [GO] 2020―Aug―06 Association of history of cerebrovascular disease with severity of COVID-19 Timo Siepmann, Annahita Sedghi, Jessica Barlinn, Katja de With, Lutz Mirow, Martin Wolz, et al. (+16)
187 [GO] 2020―Aug―06 Neurological manifestations in 404 COVID-19 patients in Washington State Pinky Agarwal, Sudeshna Ray, Arina Madan, Brad Tyson
188 [GO] 2020―Aug―04 Neurological comorbidity and severity of COVID-19 Alberto Romagnolo, Roberta Balestrino, Gabriele Imbalzano, Giovannino Ciccone, Franco Riccardini, Carlo Alberto Artusi, et al. (+8)
189 [GO] 2020―Aug―04 Reply to "Guillain-Barré syndrome in the COVID-19 era another occasional cluster?": Insights from two distinct clusters of Guillain-Barré syndrome detected in Europe in the COVID-19 era Alessandro Marini, Alberto Vogrig, Francesco Bax, Gaia Pellitteri, Andrea Surcinelli, Mariarosaria Valente, Gian Luigi Gigli
190 [GO] 2020―Aug―01 Exploring the clinical association between neurological symptoms and COVID-19 pandemic outbreak: a systematic review of current literature Davide Tiziano Di Carlo, Nicola Montemurro, Giandomenico Petrella, Gabriele Siciliano, Roberto Ceravolo, Paolo Perrini
191 [GO] 2020―Aug―01 Causality in COVID-19-associated stroke: a uniform case definition for use in clinical research Alberto Vogrig, Daniele Bagatto, Gian Luigi Gigli, Milena Cobelli, Serena D’Agostini, Claudio Bnà, Mauro Morassi
192 [GO] 2020―Jul―30 Immune-mediated neurological syndromes in SARS-CoV-2-infected patients Antoine Guilmot, Sofia Maldonado Slootjes, Amina Sellimi, Maroussia Bronchain, Bernard Hanseeuw, Leila Belkhir, et al. (+16)
193 [GO] 2020―Jul―28 Psychological consequences of COVID-19 pandemic in Italian MS patients: signs of resilience? Rocco Capuano, Manuela Altieri, Alvino Bisecco, Alessandro d’Ambrosio, Renato Docimo, Daniela Buonanno, et al. (+5)
194 [GO] 2020―Jul―25 Comment on “Stroke in patients with SARS-CoV-2 infection: case series” from a London hospital experience Anan Shtaya, Sarah Trippier, Rita Ghatala, Gillian Cluckie, Liqun Zhang
195 [GO] 2020―Jul―21 COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable? Luigi Ferini-Strambi, Maria Salsone
196 [GO] 2020―Jul―21 Amyotrophic lateral sclerosis patients’ and caregivers' distress and loneliness during COVID-19 lockdown Monica Consonni, Alessandra Telesca, Eleonora Dalla Bella, Enrica Bersano, Giuseppe Lauria
197 [GO] 2020―Jul―20 Excess neurological death in New York City after the emergence of COVID-19 Adam de Havenon, John P. Ney, Brian Callaghan, Shadi Yaghi, Jennifer J. Majersik
198 [GO] 2020―Jul―20 A systematic review of neurological symptoms and complications of COVID-19 Xiangliang Chen, Sarah Laurent, Oezguer A. Onur, Nina N. Kleineberg, Gereon R. Fink, Finja Schweitzer, Clemens Warnke
199 [GO] 2020―Jul―20 Impact of the COVID-19 outbreak on acute stroke care L. A. Rinkel, J. C. M. Prick, R. E. R. Slot, N. M. A. Sombroek, J. Burggraaff, A. E. Groot, et al. (+10)
200 [GO] 2020―Jul―18 Isolated post SARS-CoV-2 diplopia Thiago Gonçalves dos Santos Martins
201 [GO] 2020―Jul―16 Not only pulmonary rehabilitation for critically ill patients with COVID-19 Anna Estraneo, Marco Ciapetti, Carlo Gaudiosi, Antonello Grippo
202 [GO] 2020―Jul―13 Significant reduction of physical activity in patients with neuromuscular disease during COVID-19 pandemic: the long-term consequences of quarantine Vincenzo Di Stefano, Giuseppe Battaglia, Valerio Giustino, Andrea Gagliardo, Michele D’Aleo, Ottavio Giannini, et al. (+2)
203 [GO] 2020―Jul―11 Frontal encephalopathy related to hyperinflammation in COVID-19 Ilaria Cani, Valentina Barone, Roberto D’Angelo, Lara Pisani, Vincenzo Allegri, Luca Spinardi, et al. (+6)
204 [GO] 2020―Jul―11 Impact of COVID-19 lockdown on sleep quality in university students and administration staff Sara Marelli, Alessandra Castelnuovo, Antonella Somma, Vincenza Castronovo, Samantha Mombelli, Daniela Bottoni, et al. (+3)
205 [GO] 2020―Jul―11 Control of SARS-CoV-2 infection in rituximab-treated neuroimmunological patients Marcel S. Woo, David Steins, Vivien Häußler, Matin Kohsar, Friedrich Haag, Birte Elias-Hamp, et al. (+4)
206 [GO] 2020―Jul―10 Telemedicine for neuromuscular disorders during the COVID-19 outbreak Matteo Garibaldi, Gabriele Siciliano, Giovanni Antonini
207 [GO] 2020―Jul―09 Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-19 Markus Ameres, Susanne Brandstetter, Antoaneta A. Toncheva, Michael Kabesch, David Leppert, Jens Kuhle, Sven Wellmann
208 [GO] 2020―Jul―07 Mild COVID-19 infection in an NMO patient treated with tocilizumab: a confirmation of anti-IL-6 protective role? Vittorio Mantero, Andrea Rigamonti, Paola Basilico, Marta Crespi, Roberto Balgera, Andrea Salmaggi
209 [GO] 2020―Jul―07 Impact of COVID-19 on U.S. and Canadian neurologists’ therapeutic approach to multiple sclerosis: a survey of knowledge, attitudes, and practices Farrah J. Mateen, Shawheen Rezaei, Nicholas Alakel, Brittany Gazdag, Aditya Ravi Kumar, Andre Vogel
210 [GO] 2020―Jul―07 COVID-19 reveals influence of physical activity on symptom severity in hereditary spastic paraplegia Lotte van de Venis, Bart P. C. van de Warrenburg, Vivian Weerdesteyn, Bas J. H. van Lith, Alexander C. H. Geurts, Jorik Nonnekes
211 [GO] 2020―Jun―29 Transverse myelitis related to COVID-19 infection Alexandros Zachariadis, Anca Tulbu, Davide Strambo, Alexis Dumoulin, Gabriella Di Virgilio
212 [GO] 2020―Jun―29 What has caused the fall in stroke admissions during the COVID-19 pandemic? Richard Perry, Azra Banaras, David J. Werring, Robert Simister
213 [GO] 2020―Jun―27 Large artery ischemic stroke in severe COVID-19 Fernando Sierra-Hidalgo, Nuria Muñoz-Rivas, Pedro Torres Rubio, Kateri Chao, Mercedes Villanova Martínez, Paz Arranz García, Eva Martínez-Acebes
214 [GO] 2020―Jun―25 COVID-19 in dimethyl fumarate-treated patients with multiple sclerosis Vittorio Mantero, Lucia Abate, Paola Basilico, Roberto Balgera, Andrea Salmaggi, Bardia Nourbakhsh, Christian Cordano
215 [GO] 2020―Jun―25 Acute inflammatory demyelinating polyneuritis in association with an asymptomatic infection by SARS-CoV-2 Martina Bracaglia, Ilaria Naldi, Alessandra Govoni, Donatella Brillanti Ventura, Patrizia De Massis
216 [GO] 2020―Jun―24 Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient Lucia Princiotta Cariddi, Payam Tabaee Damavandi, Federico Carimati, Paola Banfi, Alessandro Clemenzi, Margherita Marelli, et al. (+4)
217 [GO] 2020―Jun―24 Characteristics and clinical course of Covid-19 patients admitted with acute stroke Lucio D’Anna, Joseph Kwan, Zoe Brown, Omid Halse, Sohaa Jamil, Dheeraj Kalladka, et al. (+2)
218 [GO] 2020―Jun―23 Guillain-Barré syndrome in the COVID-19 era: another occasional cluster? Laurent Tatu, Sandra Nono, Simone Grácio, Serdar Koçer
219 [GO] 2020―Jun―20 First case of SARS-COV-2 sequencing in cerebrospinal fluid of a patient with suspected demyelinating disease Renan Barros Domingues, Maria Cássia Mendes-Correa, Fernando Brunale Vilela de Moura Leite, Ester Cerdeira Sabino, Diego Zanotti Salarini, Ingra Claro, et al. (+5)
220 [GO] 2020―Jun―19 Neurological involvement of coronavirus disease 2019: a systematic review Malik Ghannam, Qasem Alshaer, Mustafa Al-Chalabi, Lara Zakarna, Jetter Robertson, Georgios Manousakis
221 [GO] 2020―Jun―17 Cerebral involvement in COVID-19 is associated with metabolic and coagulation derangements: an EEG study Giordano Cecchetti, Marco Vabanesi, Raffaella Chieffo, Giovanna Fanelli, Fabio Minicucci, Federica Agosta, et al. (+3)
222 [GO] 2020―Jun―12 Isolated post SARS-CoV-2 diplopia Alice Faucher, Pierre-Antoine Rey, Elise Aguadisch, Bertrand Degos
223 [GO] 2020―Jun―12 Bilateral carotid artery dissection in a SARS-CoV-2 infected patient: causality or coincidence? Mauro Morassi, Barbara Bigni, Milena Cobelli, Lodoviga Giudice, Claudio Bnà, Alberto Vogrig
224 [GO] 2020―Jun―12 Mixed central and peripheral nervous system disorders in severe SARS-CoV-2 infection H. Chaumont, A. San-Galli, F. Martino, C. Couratier, G. Joguet, M. Carles, et al. (+2)
225 [GO] 2020―Jun―11 COVID-19 encephalopathy: detection of antibodies against SARS-CoV-2 in CSF Daniela Andriuta, Pierre-Alexandre Roger, William Thibault, Bénédicte Toublanc, Chloe Sauzay, Sandrine Castelain, et al. (+2)
226 [GO] 2020―Jun―11 Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis Lei Wang, Yin Shen, Man Li, Haoyu Chuang, Youfan Ye, Hongyang Zhao, Haijun Wang
227 [GO] 2020―Jun―03 A review of pathophysiology and neuropsychiatric manifestations of COVID-19 Madhu Jasti, Krishna Nalleballe, Vasuki Dandu, Sanjeeva Onteddu
228 [GO] 2020―Jun―03 COVID-19 in teriflunomide-treated patients with multiple sclerosis Amir Hadi Maghzi, Maria K. Houtchens, Paolo Preziosa, Carolina Ionete, Biljana D. Beretich, James M. Stankiewicz, et al. (+9)
229 [GO] 2020―Jun―03 Mild COVID-19 symptoms despite treatment with teriflunomide and high-dose methylprednisolone due to multiple sclerosis relapse Nora Möhn, Firas Saker, Viktoria Bonda, Gesine Respondek, Marcus Bachmann, Matthias Stoll, et al. (+3)
230 [GO] 2020―Jun―03 Neurological complications of COVID-19: a preliminary review A. Pryce-Roberts, M. Talaei, N. P. Robertson
231 [GO] 2020―May―30 COVID-19-associated acute disseminated encephalomyelitis (ADEM) Timothy Parsons, Sarah Banks, Chay Bae, Joel Gelber, Hussein Alahmadi, Matthew Tichauer
232 [GO] 2020―May―27 Onset of Covid-19 with impaired consciousness and ataxia: a case report R. Balestrino, M. Rizzone, M. Zibetti, A. Romagnolo, C. A. Artusi, E. Montanaro, L. Lopiano
233 [GO] 2020―May―26 Non-epileptic seizures in autonomic dysfunction as the initial symptom of COVID-19 Kazimierz Logmin, Mohamed Karam, Tanja Schichel, Jens Harmel, Lars Wojtecki
234 [GO] 2020―May―26 Acute transverse myelitis after COVID-19 pneumonia Maike Munz, Swen Wessendorf, Georgios Koretsis, Friedemann Tewald, Reem Baegi, Stefan Krämer, et al. (+2)
235 [GO] 2020―May―26 Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms Zhiqiang Zhou, Huicong Kang, Shiyong Li, Xu Zhao
236 [GO] 2020―May―26 Neurological manifestations of COVID-19: a review of what we know so far Panagiotis Gklinos
237 [GO] 2020―May―26 Miller-Fisher-like syndrome related to SARS-CoV-2 infection (COVID 19) Jessica Fernández-Domínguez, Elena Ameijide-Sanluis, Carmen García-Cabo, Raquel García-Rodríguez, Valentín Mateos
238 [GO] 2020―May―26 Post-infectious Guillain-Barré syndrome related to SARS-CoV-2 infection: a case report Nilo Riva, Tommaso Russo, Yuri Matteo Falzone, Marta Strollo, Stefano Amadio, Ubaldo Del Carro, et al. (+3)
239 [GO] 2020―May―25 Quantitative evaluation of olfactory dysfunction in hospitalized patients with Coronavirus [2] (COVID-19) Georgios Tsivgoulis, Paraskevi C. Fragkou, Alexander Delides, Emmanouil Karofylakis, Dimitra Dimopoulou, Petros P. Sfikakis, Sotirios Tsiodras
240 [GO] 2020―May―20 Neurological manifestations associated with COVID-19: a review and a call for action Matilde Leonardi, Alessandro Padovani, Justin C. McArthur
241 [GO] 2020―May―20 Stroke in patients with SARS-CoV-2 infection: case series Mauro Morassi, Daniele Bagatto, Milena Cobelli, Serena D’Agostini, Gian Luigi Gigli, Claudio Bnà, Alberto Vogrig
242 [GO] 2020―May―19 Guillain-Barré syndrome in the COVID-19 era: just an occasional cluster? Gian Luigi Gigli, Francesco Bax, Alessandro Marini, Gaia Pellitteri, Anna Scalise, Andrea Surcinelli, Mariarosaria Valente
243 [GO] 2020―May―12 Acute polyradiculoneuritis with locked-in syndrome in a patient with Covid-19 Thomas Pfefferkorn, Rainer Dabitz, Thomas von Wernitz-Keibel, Johannes Aufenanger, Martina Nowak-Machen, Hendrik Janssen
244 [GO] 2020―May―12 Tele-health in neurology: an indispensable tool in the management of the SARS-CoV-2 epidemic Ruggero Capra, Flavia Mattioli
245 [GO] 2020―Apr―24 Guillain-Barré syndrome following COVID-19: new infection, old complication? Marina Padroni, Vincenzo Mastrangelo, Gian Maria Asioli, Lucia Pavolucci, Samir Abu-Rumeileh, Maria Grazia Piscaglia, et al. (+3)
246 [GO] 2020―Apr―17 Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2 M. D. Willis, N. P. Robertson
 [1] 

246 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.008 sec